These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 26652481)
21. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. Reddy AJ; Zaas AK; Hanson KE; Palmer SM J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480 [TBL] [Abstract][Full Text] [Related]
22. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Waldman WJ; Knight DA; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS Transplantation; 1999 Sep; 68(6):814-25. PubMed ID: 10515382 [TBL] [Abstract][Full Text] [Related]
23. Cytomegaloviral Retinitis in a Heart Transplant Patient: Case Report and Review of the Literature. Janicka-Maszke Z; Konopa J; Ślizień M; Glasner P; Chamienia A; Dębska-Ślizień A; Michalska-Małecka K; Glasner L Transplant Proc; 2022 May; 54(4):1158-1166. PubMed ID: 35760629 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. El Chaer F; Mori N; Shah D; Oliver N; Wang E; Jan A; Doan V; Tverdek F; Tayar J; Ariza-Heredia E; Chemaly RF Antiviral Res; 2016 Nov; 135():91-96. PubMed ID: 27594527 [TBL] [Abstract][Full Text] [Related]
26. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833 [TBL] [Abstract][Full Text] [Related]
27. Intraocular therapy for cytomegalovirus retinitis. Palestine AG J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527 [TBL] [Abstract][Full Text] [Related]
28. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA. Ohta H; Matsuda Y; Tokimasa S; Sawada A; Kim JY; Sashihara J; Amo K; Miyagawa H; Tanaka-Taya K; Yamamoto S; Tano Y; Aono T; Yamanishi K; Okada S; Hara J Bone Marrow Transplant; 2001 Jun; 27(11):1141-5. PubMed ID: 11551024 [TBL] [Abstract][Full Text] [Related]
29. Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant. Tawse KL; Baumal CR J AAPOS; 2014 Feb; 18(1):78-80. PubMed ID: 24568990 [TBL] [Abstract][Full Text] [Related]
30. EFFICACY OF MARIBAVIR IN VALGANCICLOVIR-RESISTANT CYTOMEGALOVIRUS RETINITIS. Tsui JC; Huang V; Kolomeyer AM; Miller CG; Mishkin A; Maguire AM Retin Cases Brief Rep; 2024 Mar; 18(2):164-167. PubMed ID: 36730596 [TBL] [Abstract][Full Text] [Related]
31. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS. Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547 [TBL] [Abstract][Full Text] [Related]
32. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Schneider EW; Elner SG; van Kuijk FJ; Goldberg N; Lieberman RM; Eliott D; Johnson MW Retina; 2013 Oct; 33(9):1791-9. PubMed ID: 23584702 [TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Ufret-Vincenty RL; Singh RP; Lowder CY; Kaiser PK Am J Ophthalmol; 2007 Feb; 143(2):334-5. PubMed ID: 17258523 [TBL] [Abstract][Full Text] [Related]
34. Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient. Kneidinger N; Giessen C; von Wulffen W; Milger K; Schramm R; Jäger G; Nitschko H; Striebinger H; Behr J; Neurohr C Int J Infect Dis; 2014 Nov; 28():140-2. PubMed ID: 25267276 [TBL] [Abstract][Full Text] [Related]
35. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab. Song WK; Min YH; Kim YR; Lee SC Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of valganciclovir in the treatment of cytomegalovirus disease in kidney and pancreas transplant recipients. Luan FL; Chopra P; Park J; Norman S; Cibrik D; Ojo A Transplant Proc; 2006 Dec; 38(10):3673-5. PubMed ID: 17175363 [TBL] [Abstract][Full Text] [Related]
38. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact]. Reusser P; Hostettler B; Attehbofer R Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510 [TBL] [Abstract][Full Text] [Related]
39. Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy. Yanagisawa K; Ogawa Y; Hosogai M; Todokoro D; Mitsui T; Yokohama A; Kishi S; Handa H J Infect Chemother; 2017 Aug; 23(8):572-575. PubMed ID: 28389165 [TBL] [Abstract][Full Text] [Related]
40. Clinical features and outcomes of cytomegalovirus retinitis after transplantation. Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]